JPRN-UMIN000014337已完成未知
Study about the efficacy of metformin to immune function in healthy volunteers. - Study about the efficacy of metformin to immune function in healthy volunteers.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Subjects who have symptoms which are judged to require follow-up or treatment. 2. Subjects who have previous medical history of hepatic disease, renal disease, cardiovascular disease, endocrine disease, gastrointestinal disease, respiratory disease, blood disorders and malignancy. 3. Subjects who have previous medical history of lactic acidosis. 4. Subjects who are allergic to medicines. 5. Subjects who need to take other medicines from 7 days before the study to the end of it. 6. Subjects who have drinking habit. 7. Subjects who drink caffeine-containing beverage in daily average of 1.8 L or more (coffee, tea, green tea, cola, health drink, etc.) 8. Subjects who smoke 2 packs or more in daily average. 9. Subjects who have been enrolled in the other clinical trials within last 4 months before the administration of metformin and administered any investigational new drugs. 10. Subjects who have made a blood donation prior to the administration of metformin. 11. Subjects who have been shown any problems at health examination. 12. Pregnant wouman 13. Other subjects who are judged to be ineligible in this trial by the investigator.
研究者
相似试验
已完成
不适用
Study about the efficacy of metformin to immune function in cancer patients.cancer and sarcomaJPRN-UMIN000014689Okayama University Hospital30
尚未招募
不适用
The effects of metformin on immune function.immunometabolismeffect of metabolism on immunity1002844010018424NL-OMON41133niversitair Medisch Centrum Sint Radboud12
尚未招募
2 期
Metformin in the prevention of preeclampsiaPre-eclampsiapreeclampsia.IRCT20230730058975N1Esfahan University of Medical Sciences160
进行中(未招募)
1 期
Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.Study to evaluate the effect of metformin in the prevention of hyperglycemiain HR[+]/HER2[–] PIK3CA-mutated advanced breast cancer patients treatedwith alpelisib plus endocrine therapy. The Metallica study.CTIS2024-511295-33-00Medica Scientia Innovation Research S.L.88
已完成
2 期
Investigating the effect of metformin on the activity of systemic lupus erythematosusIRCT20220817055730N1Ahvaz University of Medical Sciences64
